Nurix Therapeutics (NRIX) Earnings Date, Estimates & Call Transcripts $24.80 +1.23 (+5.22%) (As of 09/13/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateOct. 10EstimatedActual EPS (Jul. 11) -$0.71 Missed By -$0.08 Consensus EPS (Jul. 11) -$0.63 Earnings Press Release Get Nurix Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for NRIX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNRIX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NRIX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyWar on Elon Escalates… Elon Musk just built a supercomputer in Memphis, Tennessee. It took him only 122 days. Dubbed “Colossus,” this supercomputer aims to become the most powerful AI training system in the world. Housed in a 785,000 sq. ft facility in Memphis, Colossus will soon require 150 megawatts of electricity per day. That’s about equal to the amount of energy needed to power 100,000 homes per year. Click here and take notes. Nurix Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.87)($0.81)($0.84)Q2 20242($0.88)($0.72)($0.80)Q3 20242($0.90)($0.68)($0.79)Q4 20242($0.92)($0.71)($0.82)FY 20248($3.57)($2.92)($3.25)Q1 20251($0.73)($0.73)($0.73)Q2 20251($0.75)($0.75)($0.75)Q3 20251($0.78)($0.78)($0.78)Q4 20251($0.80)($0.80)($0.80)FY 20254($3.06)($3.06)($3.06)NRIX Earnings Date and InformationNurix Therapeutics last released its earnings results on July 11th, 2024. The reported ($0.71) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.08. The firm earned $12.09 million during the quarter, compared to analysts' expectations of $19.35 million. Nurix Therapeutics has generated ($2.92) earnings per share over the last year (($2.92) diluted earnings per share). Earnings for Nurix Therapeutics are expected to grow in the coming year, from ($2.95) to ($2.73) per share. Nurix Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 10th, 2024 based off prior year's report dates.Read More Nurix Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 10/10/2024(Estimated)------- 7/11/2024Q2 2024($0.63)($0.71)($0.08)($0.71)$19.35 million$12.09 million 4/10/2024Q1 2024($0.80)($0.76)+$0.04($0.76)$14.58 million$16.59 million 2/15/2024Q4 2023($0.51)($0.77)($0.26)($0.77)$30.66 million$15.16 million 10/12/2023Q3 2023($0.84)($0.68)+$0.16($0.68)$19.98 million$18.47 million 7/13/2023Q2 2023($0.57)($0.45)+$0.12($0.45)$21.96 million$30.68 million 4/13/2023Q1 2023($0.90)($0.75)+$0.15($0.75)$10.49 million$12.69 million Get the Latest News and Ratings for NRIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nurix Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/9/2023Q4 2022($0.68)($0.87)($0.19)($0.87)$19.64 million$6.78 million 10/6/2022Q3 2022($0.99)($0.90)+$0.09($0.90)$12.31 million$10.79 million 7/7/2022Q2 2022($1.00)($1.01)($0.01)($1.01)$10.09 million$11.43 million 4/7/2022Q1 2022($0.89)($0.95)($0.06)($0.95)$8.77 million$9.62 million 1/27/2022Q4 2021($0.67)($0.85)($0.18)($0.85)$14.99 million$7.40 million 10/14/2021Q3($0.63)($0.65)($0.02)($0.65)$8.73 million$10.25 million 7/12/2021Q2 2021($0.54)($0.60)($0.06)($0.60)$9.24 million$7.09 million 4/12/2021Q1 2021($0.45)($0.63)($0.18)($0.63)$8.40 million$5.01 million 2/16/2021Q4 2020($0.53)($0.51)+$0.02($0.51)$5.41 million$6.69 million10/19/2020Q3($0.4130)($0.59)($0.1770)($0.59)$7.35 million$4.09 million Nurix Therapeutics Earnings - Frequently Asked Questions When is Nurix Therapeutics's earnings date? Nurix Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 10th, 2024 based off last year's report dates. Learn more on NRIX's earnings history. Did Nurix Therapeutics beat their earnings estimates last quarter? In the previous quarter, Nurix Therapeutics (NASDAQ:NRIX) missed the analysts' consensus estimate of ($0.63) by $0.08 with a reported earnings per share (EPS) of ($0.71). Learn more on analysts' earnings estimate vs. NRIX's actual earnings. How much revenue does Nurix Therapeutics generate each year? Nurix Therapeutics (NASDAQ:NRIX) has a recorded annual revenue of $62.30 million. How much profit does Nurix Therapeutics generate each year? Nurix Therapeutics (NASDAQ:NRIX) has a recorded net income of -$143.95 million. NRIX has generated -$2.92 earnings per share over the last four quarters. What is Nurix Therapeutics's EPS forecast for next year? Nurix Therapeutics's earnings are expected to grow from ($2.95) per share to ($2.73) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Praxis Precision Medicines Earnings Date Arvinas Earnings Date Ligand Pharmaceuticals Earnings Date COMPASS Pathways Earnings Date Avidity Biosciences Earnings Date Crinetics Pharmaceuticals Earnings Date ADMA Biologics Earnings Date Arcellx Earnings Date TG Therapeutics Earnings Date Biohaven Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:NRIX) was last updated on 9/14/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredInvest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges ...Deal Maker | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
